82 institutions reported holding $452.8M of BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) in SEC 13F filings for 2026-06-30. Largest institutional holders: Cormorant Asset Management, LP ($136.2M), DEERFIELD MANAGEMENT COMPANY, L.P. ($37.2M), Omega Fund Management, LLC ($25.1M), EcoR1 Capital, LLC ($21.5M), Alphabet Inc. ($21.5M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30